By Joseph Williams on 5th November 2024

New Publication by BOPA Member and AI Specialist Advisory Group (SAG) Co-Chair Pinkie Chambers

From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancers New Publication by BOPA Member and AI Specialist Advisory Group (SAG)…

Read article
By BOPA Executive Committee on 4th November 2024

CRUK Consent Form Updates – MPN and Nivolumab with Relatlimab for melanoma

Dear All, I am happy to inform you that the MPN consent forms have been reviewed and updated. Furthermore, a new consent form has been added  form for Nivolumab with…

Read article
By BOPA Committee on 4th November 2024

BOPA Podcast – Let’s Talk About Acute Oncology

The next episode of Let’s Talk About SACT is Let’s talk about Acute Oncology. In this episode we are joined by Caroline Wilson and Alison Taylor. We discuss what acute…

Read article
By BOPA Passport pillar on 28th October 2024

Request for membership to create or review content for BOPA Digital SACT passport

Dear Member, It has been 12 months since the launch of the “BOPA SACT Verification Passport”. In order to optimise user experience of the Passport, we need to have new…

Read article
By BOPA Research Committee on 28th October 2024

Hypercalcaemia of malignancy survey

Dear colleagues, Hypercalcaemia of malignancy is the commonest metabolic complication in cancer patients and there is a lack of evidence in this area, leading to potential variation in clinical practice.…

Read article
By BOPA Passport Pillar on 22nd October 2024

Reminder of BOPA SACT Verification Passport Grandparenting Deadline

Dear member,   As of the beginning of this month, we have 139 registered sites and 1,600 users subscribed to the SACT verification passport. This is a fabulous uptake and…

Read article
By BOPA IO SAG on 21st October 2024

BOPA Immunotherapy Specialist Advisory Group (SAG) – Abstract Accepted to ESMO IO 2024

A message from the BOPA Immunotherapy SAG: It brings us great pleasure to inform you that the Research & Analysis pillar of the BOPA Immunotherapy SAG has successfully submitted abstract…

Read article
By BOPA on 17th October 2024

CRUK Publication update: National SACT regimen specific consent forms for HPB, Lung and Welsh adult generic forms

Dear BOPA memebers,   I am pleased to inform you that consent forms for the following groups have been reviewed and updated   1. Welsh generic adult SACT and immunotherapy…

Read article
By BOPA Executive Committee on 9th October 2024

Proposed BOPA Vision – We want to hear from you! Have your say today

Do you feel reflected in BOPA’s values, mission and vision? Would you add anything else?  Please contact us now – Feedback on the Proposed Vision (office.com) The Vision can be…

Read article
By BOPA Committee on 8th October 2024

UKMS Pharmacy Group – Education Day, November 5th 2024

The UK Myeloma Society Pharmacy Group (a special-interest group affiliated to BOPA) is running its 2nd Annual Educational Meeting on Tuesday 5th November from 12 Noon to 4.30pm. The meeting…

Read article
By BOPA research subcommittee on 8th October 2024

Survey: Clinical Research Priorities for UK Cardio-Oncology

Dear members, The NIHR-BHF Cardiovascular Partnership theme in Cardio-Oncology is a new project bringing cardiology and oncology specialists together with patient representatives. Its aims are to inform cardio-oncology research priorities,…

Read article
By BOPA on 4th October 2024

Survey request for members thinking about credentialing as a Consultant Pharmacist

In May 2024 – if you had any intentions to start, re-submit, or progress your consultant portfolio within the next 18-24 months please complete this survey. You do not need…

Read article